Partnership for Research on Ebola VACcinations (PREVAC)
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
- Acronyms PREVAC
- 12 Apr 2017 Status changed from not yet recruiting to recruiting.
- 13 Mar 2017 Planned number of patients changed from 4900 to 5500.
- 13 Mar 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.